Equine intraocular melanocytic neoplasia

Viewing 0 reply threads
  • Author
    Posts
    • #21968

      Equine intraocular melanocytic neoplasia
      Can Vet J. 2024 Oct;65(10):1048-1054.
      Authors
      Amber L Labelle 1 , Anne M Gemensky Metzler 1 , Richard J McMullen Jr 1 , K Tomo Wiggans 1 , Philippe Labelle 1 , Ralph E Hamor 1
      Affiliation

      1 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Illinois Urbana-Champaign, 1008 West Hazelwood Drive, Urbana, Illinois 61802, USA.

      PMID: 39355695
      PMCID: PMC11411471 (available on 2025-01-01)

      Abstract
      in English, French

      Objective: To describe the clinical appearance, histopathology, and treatment of equine intraocular melanocytic neoplasia in adult horses.

      Animals and procedure: A retrospective review of medical records was conducted. Data recorded included signalment, ocular examination findings, physical examination findings, therapeutic interventions, and case outcomes. Histopathologic characteristics of enucleated globes were evaluated. A Student’s t-test was used to evaluate differences in the interval from diagnosis to last known outcome between horses receiving therapeutic interventions and horses undergoing monitoring alone.

      Results: Of the 55 horses included, Arabian was the most common breed (15/55, 27%). Gray was the most common coat color (85%). Physical examination was completed for 75% of horses at time of diagnosis, and of those, 67% had cutaneous melanoma. The interval from diagnosis to last known outcome was not different (P = 0.312) between horses that underwent monitoring alone (median: 2.0 y) and those that received treatment (mean: 2.25 y).

      Conclusion: Equine intraocular melanocytic neoplasms are highly associated with cutaneous melanoma and gray coat color, and they are more prevalent than previously published reports suggest.

      Clinical relevance: A complete ophthalmic examination is indicated for all horses with cutaneous melanoma. Additional research into the timing and rationale for treatment of intraocular melanocytic neoplasia is necessary.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.